Liquid Biopsy Publikationen

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays

Ariane Hallermayr, Thomas Keßler, Moritz Fujera, Ben Liesfeld, Samuel Bernstein, Simon von Ameln, Denny Schanze, Verena Steinke-Lange, Julia M. A. Pickl,Teresa M. Neuhann, Elke Holinski-Feder

Cancers 2023, 15(20), 5024;

https://www.mdpi.com/2072-6694/15/20/5024

Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants

Ariane Hallermayr, Teresa M. Neuhann, Verena Steinke-Lange, Florentine Scharf, Andreas Laner, Roland Ewald, Ben Liesfeld, Elke Holinski-Feder, Julia M. A. Pickl

Frontiers in Oncology, Volume 12, (2022);

https://www.frontiersin.org/articles/10.3389/fonc.2022.1014592/full

Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients

Ariane Hallermayr, Tobias Wohlfrom, Verena Steinke-Lange, Anna Benet-Pagès, Florentine Scharf, Ellen Heitzer, Ulrich Mansmann, Christopher Haberl, Maike de Wit, Holger Vogelsang, Markus Rentsch, Elke Holinski-Feder & Julia M. A. Pickl

Journal of Hematology & Oncology, V 15, Article number: 125 (2022);

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-022-01342-z

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management

Ariane Hallermayr, Verena Steinke-Lange, Holger Vogelsang, Markus Rentsch, Maike de Wit, Christopher Haberl, Elke Holinski-Feder and Julia M. A. Pickl

Cancers 2022, 14(3), 851;
https://doi.org/10.3390/cancers14030851

Terminvereinbarung

Formulare/Service

Hinweise für Einsender

Liquid Biopsy Publikationen

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays

Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants

Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management

Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring